Visuals
Sidebar
Data suggest mixing and matching vaccines enhance immune response against Omicron
Source: Dr. Janine Kimpel and the Medical University of Vienna .
Number of COVID-19 Omicron variant cases in Europe as of November 29, 2021, by country
In late-November 2021, the Omicron variant of SARS-CoV-2 (the virus which causes COVID-19) was designated as a variant of concern ...
The ‘kid effect’ on COVID-19 cases
Projected incident cases modeling outcomes in which new variants do or do not form and in which children are or ...
Global meat supply per capita
Source: UN Food and Agriculture Organization (FAO)
Medicare Advantage marches toward 70% penetration
Medicare Advantage is expected to continue its slow but steady growth, reaching 60% to 70% penetration sometime between 2030 and ...
Full state-by-state guide to vaccine exemptions in the US
Source: National Vaccine Information Center
One in five Americans are unwilling to get vaccinated
A September survey found that nearly one in five Americans are unwilling to get vaccinated. Source: Morning Consult
Association between COVID-19 outcomes and mask mandates, adherence, and attitudes
Using an event study design, authors estimate the treatment effect of the introduction of mask mandates (shown on the vertical ...
Vaccine effectiveness against COVID-19 infections
Differences in the virus, the host, and the study design can affect real-world vaccine effectiveness. CDC uses multiple methods to ...
Lifetime, annual, monthly, and daily prevalence of marijuana use by age.
“The COVID-19 pandemic dramatically changed the way that young people interact with one another and offers us an opportunity to ...
Telemedicine trends before and during the pandemic
Telehealth has always been in US physicians’ toolkit – but until COVID-19 adoption was relatively slow. In an early-2019 poll ...
Total vaccine doses per 100 people
"There remains a shocking imbalance in the global distribution of vaccines," WHO Director General Tedros Adhanom Ghebreyesus told a news ...
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more